Neomycin Sulfate Soluble Powder 500 mg Powder For Solution is a Health Canada–registered veterinary drug (DIN 02531437) held by Huvepharma Eood, containing Neomycin (Neomycin Sulfate). Health Canada lists its status as Marketed (status date 20 Mar 2024).
Health Canada registration
| DIN | 02531437 |
|---|---|
| Brand name | Neomycin Sulfate Soluble Powder |
| Active ingredient | Neomycin (Neomycin Sulfate) |
| Strength | 500 mg |
| Dosage form | Powder For Solution |
| Route | Oral |
| Company | Huvepharma Eood |
| Status | Marketed — 20 Mar 2024 |
| Class | Veterinary |
| ATC | |
| AHFS | 08:12.12.08 |
| Regulator record | Health Canada DPD entry · Product monograph |
Regulator price references for Neomycin (Neomycin Sulfate)
Published list or reimbursement prices for Neomycin (Neomycin Sulfate) presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.
| Country | Product | Strength | Pack | Price | Type | Source | As of |
|---|---|---|---|---|---|---|---|
| Canada | Optimyxin Plus | 1.75mg | 10,000U/2.5MG/0.025MG PER ML EYE/EAR SOLUTION SOLUTION per unit | 0.73 CAD | reimbursement | Provincial formulary SK | 2026-09-24 |
| Canada | Viaderm KC | 2.5mg | 2.5mg/0.25mg/1mg/gr Ointment Ointment per unit | 0.74 CAD | reimbursement | Provincial formulary NL | 2026-09-24 |
| Canada | Cortisporin | 3.5mg | 1.41 CAD | reimbursement | Provincial formulary BC | 2026-09-24 |
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. Because this DIN is marketed in Canada, supply normally comes through the Canadian channel; where the Canadian presentation is short or discontinued, the registrations above show which regulated markets hold an equivalent that can be imported under the Special Access Programme or for clinical comparator use. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Neomycin Sulfate Soluble Powder (DIN 02531437) marketed in Canada?
Yes. Health Canada lists DIN 02531437 as Marketed as of 20 Mar 2024.
Who holds the Canadian licence for this product?
Huvepharma Eood is the company of record in the Health Canada Drug Product Database.
Is the same medicine registered outside Canada?
No same-molecule registration has been matched in the 56 national registries Nexara Health tracks. Contact us to check manually.
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02531437, status date 2024-03-20; price sources: Provincial formulary BC, Provincial formulary NL, Provincial formulary SK. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02531437, status date 2024-03-20; price sources: Provincial formulary BC, Provincial formulary NL, Provincial formulary SK.
Health Canada Drug Product Database (DPD), DIN 02531437, status date 2024-03-20; price sources: Provincial formulary BC, Provincial formulary NL, Provincial formulary SK. Last reviewed 2026-09-28. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.